Alexei Basnakian
Concepts (345)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deoxyribonuclease I | 11 | 2020 | 34 | 3.990 |
Why?
| Endodeoxyribonucleases | 11 | 2021 | 44 | 3.310 |
Why?
| DNA Fragmentation | 12 | 2021 | 55 | 2.900 |
Why?
| Apoptosis | 16 | 2021 | 1101 | 2.760 |
Why?
| Lipoproteins, LDL | 13 | 2014 | 170 | 2.680 |
Why?
| Kidney Tubules | 8 | 2020 | 60 | 2.070 |
Why?
| Epithelial Cells | 8 | 2020 | 209 | 1.800 |
Why?
| Atherosclerosis | 8 | 2015 | 214 | 1.470 |
Why?
| Kidney Diseases | 4 | 2021 | 214 | 1.410 |
Why?
| In Situ Nick-End Labeling | 5 | 2021 | 57 | 1.130 |
Why?
| Oxidative Stress | 6 | 2021 | 770 | 1.010 |
Why?
| Animals | 43 | 2022 | 13187 | 0.970 |
Why?
| Endothelium, Vascular | 4 | 2014 | 252 | 0.970 |
Why?
| Deoxyribonucleases | 3 | 2021 | 23 | 0.880 |
Why?
| DNA Topoisomerases | 1 | 2021 | 3 | 0.780 |
Why?
| Kidney | 6 | 2021 | 665 | 0.770 |
Why?
| Enzyme Inhibitors | 6 | 2017 | 391 | 0.770 |
Why?
| DNA | 5 | 2020 | 541 | 0.760 |
Why?
| DNA Breaks | 1 | 2020 | 3 | 0.750 |
Why?
| DNA Damage | 4 | 2021 | 301 | 0.730 |
Why?
| Cell Line | 10 | 2021 | 1000 | 0.730 |
Why?
| DNA Repair | 1 | 2021 | 193 | 0.700 |
Why?
| Cisplatin | 5 | 2014 | 278 | 0.690 |
Why?
| Endothelial Cells | 4 | 2010 | 269 | 0.680 |
Why?
| Cells, Cultured | 12 | 2021 | 1573 | 0.660 |
Why?
| Rats | 13 | 2020 | 3305 | 0.660 |
Why?
| Chromatin | 3 | 2007 | 151 | 0.600 |
Why?
| Small Molecule Libraries | 2 | 2014 | 68 | 0.590 |
Why?
| Graphite | 1 | 2017 | 28 | 0.570 |
Why?
| Antineoplastic Agents | 4 | 2014 | 1171 | 0.540 |
Why?
| Nanoparticles | 1 | 2017 | 145 | 0.520 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 181 | 0.510 |
Why?
| Intercellular Adhesion Molecule-1 | 4 | 2020 | 63 | 0.500 |
Why?
| Enzyme Assays | 1 | 2014 | 10 | 0.490 |
Why?
| High-Throughput Screening Assays | 1 | 2014 | 37 | 0.490 |
Why?
| Mice | 19 | 2022 | 5739 | 0.480 |
Why?
| Macrophages | 2 | 2014 | 363 | 0.470 |
Why?
| Uremia | 2 | 2010 | 12 | 0.460 |
Why?
| Carbamates | 1 | 2013 | 16 | 0.450 |
Why?
| Acetylcysteine | 2 | 2013 | 100 | 0.450 |
Why?
| Organ Preservation | 1 | 2013 | 23 | 0.440 |
Why?
| Monocytes | 3 | 2010 | 131 | 0.440 |
Why?
| Cell Death | 7 | 2015 | 181 | 0.410 |
Why?
| Mice, Knockout | 9 | 2021 | 841 | 0.410 |
Why?
| Endonucleases | 4 | 2021 | 15 | 0.370 |
Why?
| Vascular Cell Adhesion Molecule-1 | 2 | 2008 | 36 | 0.360 |
Why?
| Nucleic Acids | 1 | 2009 | 13 | 0.340 |
Why?
| Receptors, Scavenger | 1 | 2009 | 29 | 0.340 |
Why?
| Gamma Rays | 1 | 2009 | 49 | 0.340 |
Why?
| Enzyme Activation | 5 | 2015 | 276 | 0.330 |
Why?
| Humans | 31 | 2022 | 49974 | 0.330 |
Why?
| DNA Methylation | 2 | 2014 | 548 | 0.320 |
Why?
| Nerve Growth Factors | 1 | 2008 | 27 | 0.310 |
Why?
| Cadmium Chloride | 1 | 2007 | 3 | 0.300 |
Why?
| DNA Replication | 2 | 2009 | 150 | 0.290 |
Why?
| Tumor Suppressor Proteins | 1 | 2008 | 128 | 0.290 |
Why?
| Oxidoreductases | 2 | 2004 | 60 | 0.290 |
Why?
| Chromosomes | 2 | 2006 | 32 | 0.290 |
Why?
| Drosophila melanogaster | 1 | 2007 | 30 | 0.290 |
Why?
| Acute Kidney Injury | 2 | 2008 | 284 | 0.280 |
Why?
| Cell Nucleus | 2 | 2007 | 183 | 0.280 |
Why?
| Cell Line, Tumor | 6 | 2022 | 1403 | 0.280 |
Why?
| B-Lymphocytes | 1 | 2007 | 170 | 0.270 |
Why?
| Mammals | 1 | 2006 | 56 | 0.270 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 475 | 0.260 |
Why?
| RNA, Messenger | 2 | 2015 | 1105 | 0.260 |
Why?
| Cell Movement | 1 | 2006 | 247 | 0.260 |
Why?
| Coronary Vessels | 5 | 2011 | 152 | 0.250 |
Why?
| Ischemia | 2 | 2004 | 153 | 0.250 |
Why?
| Reperfusion Injury | 2 | 2002 | 87 | 0.240 |
Why?
| Disease Models, Animal | 7 | 2022 | 1455 | 0.240 |
Why?
| Prostatic Neoplasms | 1 | 2008 | 394 | 0.240 |
Why?
| Cell Adhesion | 3 | 2010 | 158 | 0.240 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 244 | 0.240 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 828 | 0.230 |
Why?
| Dose-Response Relationship, Drug | 3 | 2017 | 1376 | 0.230 |
Why?
| Signal Transduction | 6 | 2021 | 1618 | 0.230 |
Why?
| Oncolytic Virotherapy | 1 | 2022 | 16 | 0.210 |
Why?
| Kidney Failure, Chronic | 4 | 2012 | 198 | 0.210 |
Why?
| Breast Neoplasms | 2 | 2014 | 1174 | 0.210 |
Why?
| Kidney Cortex | 1 | 2002 | 22 | 0.210 |
Why?
| Acute Radiation Syndrome | 1 | 2022 | 12 | 0.210 |
Why?
| Muscle, Smooth, Vascular | 3 | 2008 | 130 | 0.200 |
Why?
| Antioxidants | 2 | 2015 | 249 | 0.200 |
Why?
| Chromans | 1 | 2022 | 37 | 0.200 |
Why?
| Renal Circulation | 1 | 2002 | 59 | 0.200 |
Why?
| Alternative Splicing | 1 | 2002 | 56 | 0.200 |
Why?
| Nanotubes, Carbon | 1 | 2022 | 66 | 0.200 |
Why?
| Radiation-Protective Agents | 1 | 2022 | 74 | 0.200 |
Why?
| Mice, Inbred C57BL | 4 | 2011 | 1816 | 0.200 |
Why?
| Vitamin E | 1 | 2022 | 81 | 0.190 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 595 | 0.190 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2021 | 77 | 0.180 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2020 | 36 | 0.180 |
Why?
| Thrombomodulin | 1 | 2020 | 27 | 0.180 |
Why?
| Carcinoma, Hepatocellular | 1 | 2022 | 191 | 0.180 |
Why?
| Rats, Sprague-Dawley | 4 | 2013 | 1597 | 0.180 |
Why?
| Caspases | 3 | 2013 | 104 | 0.170 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2020 | 78 | 0.170 |
Why?
| Cell Survival | 2 | 2014 | 600 | 0.170 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 90 | 0.170 |
Why?
| Hydrazones | 1 | 2019 | 5 | 0.170 |
Why?
| Autophagy | 1 | 2021 | 169 | 0.170 |
Why?
| Acinetobacter baumannii | 1 | 2019 | 13 | 0.170 |
Why?
| Urea | 2 | 2010 | 77 | 0.170 |
Why?
| Drug Resistance, Bacterial | 1 | 2019 | 71 | 0.160 |
Why?
| Liver Neoplasms | 1 | 2022 | 326 | 0.160 |
Why?
| Flow Cytometry | 2 | 2015 | 476 | 0.160 |
Why?
| Molecular Structure | 2 | 2019 | 297 | 0.150 |
Why?
| Staphylococcus aureus | 2 | 2019 | 326 | 0.150 |
Why?
| Brain | 2 | 2017 | 1328 | 0.150 |
Why?
| RNA, Small Interfering | 2 | 2009 | 215 | 0.150 |
Why?
| Heme Oxygenase (Decyclizing) | 1 | 2017 | 6 | 0.150 |
Why?
| Etoposide | 2 | 2008 | 72 | 0.150 |
Why?
| Transfection | 2 | 2009 | 354 | 0.150 |
Why?
| Microscopy, Fluorescence | 2 | 2009 | 162 | 0.140 |
Why?
| Profilins | 1 | 2017 | 16 | 0.140 |
Why?
| Caspase 3 | 1 | 2017 | 97 | 0.140 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2017 | 50 | 0.140 |
Why?
| Risk Assessment | 2 | 2022 | 1259 | 0.140 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 40 | 0.140 |
Why?
| Time Factors | 2 | 2017 | 2903 | 0.140 |
Why?
| Mutation, Missense | 1 | 2017 | 105 | 0.140 |
Why?
| Liver | 3 | 2021 | 1115 | 0.140 |
Why?
| Spinal Cord | 1 | 2017 | 177 | 0.130 |
Why?
| Gene Knockout Techniques | 2 | 2021 | 40 | 0.130 |
Why?
| Cell Cycle | 2 | 2007 | 231 | 0.130 |
Why?
| Gold | 2 | 2014 | 136 | 0.130 |
Why?
| Cell Culture Techniques | 2 | 2007 | 99 | 0.130 |
Why?
| Cyclophilins | 1 | 2015 | 9 | 0.130 |
Why?
| Enzyme Activators | 1 | 2015 | 8 | 0.130 |
Why?
| Adenylate Kinase | 1 | 2015 | 10 | 0.130 |
Why?
| Male | 9 | 2013 | 25241 | 0.130 |
Why?
| Immunoenzyme Techniques | 1 | 2015 | 143 | 0.120 |
Why?
| Taxoids | 1 | 2014 | 37 | 0.120 |
Why?
| Risk Factors | 4 | 2015 | 3613 | 0.120 |
Why?
| Thiobarbiturates | 1 | 2014 | 23 | 0.120 |
Why?
| Antibodies | 3 | 2014 | 154 | 0.120 |
Why?
| PPAR alpha | 1 | 2015 | 58 | 0.120 |
Why?
| Inhibitory Concentration 50 | 1 | 2014 | 76 | 0.120 |
Why?
| Drug Resistance | 1 | 2014 | 63 | 0.120 |
Why?
| Cardiovascular Diseases | 2 | 2012 | 440 | 0.120 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 181 | 0.120 |
Why?
| Substrate Specificity | 1 | 2014 | 194 | 0.120 |
Why?
| Nanotubes | 1 | 2014 | 27 | 0.120 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 96 | 0.120 |
Why?
| Metformin | 1 | 2015 | 64 | 0.120 |
Why?
| Particulate Matter | 1 | 2014 | 52 | 0.120 |
Why?
| Silver | 1 | 2014 | 46 | 0.110 |
Why?
| Myocytes, Cardiac | 1 | 2015 | 125 | 0.110 |
Why?
| Zinc Acetate | 1 | 2013 | 1 | 0.110 |
Why?
| Organ Preservation Solutions | 1 | 2013 | 4 | 0.110 |
Why?
| Image Processing, Computer-Assisted | 1 | 2015 | 242 | 0.110 |
Why?
| Blotting, Western | 1 | 2015 | 601 | 0.110 |
Why?
| Refrigeration | 1 | 2013 | 5 | 0.110 |
Why?
| Neoplastic Cells, Circulating | 1 | 2014 | 74 | 0.110 |
Why?
| Anti-Bacterial Agents | 1 | 2019 | 744 | 0.110 |
Why?
| Kinetics | 1 | 2014 | 623 | 0.110 |
Why?
| Dietary Fats | 2 | 2010 | 133 | 0.110 |
Why?
| Mitochondrial Membrane Transport Proteins | 2 | 2015 | 18 | 0.110 |
Why?
| Magnetite Nanoparticles | 1 | 2012 | 21 | 0.100 |
Why?
| Oxidation-Reduction | 1 | 2013 | 322 | 0.100 |
Why?
| Cell Division | 3 | 2008 | 292 | 0.100 |
Why?
| Carotenoids | 1 | 2012 | 49 | 0.100 |
Why?
| Renal Insufficiency, Chronic | 1 | 2015 | 169 | 0.100 |
Why?
| Interferon Regulatory Factor-3 | 1 | 2011 | 9 | 0.100 |
Why?
| Genital Diseases, Female | 1 | 2011 | 17 | 0.100 |
Why?
| Bacteremia | 1 | 2012 | 90 | 0.100 |
Why?
| Cell Proliferation | 3 | 2010 | 1007 | 0.100 |
Why?
| Chlamydia muridarum | 1 | 2011 | 41 | 0.090 |
Why?
| Reproducibility of Results | 1 | 2014 | 1193 | 0.090 |
Why?
| Uterus | 1 | 2011 | 94 | 0.090 |
Why?
| Renal Dialysis | 3 | 2012 | 169 | 0.090 |
Why?
| Liver Diseases, Alcoholic | 1 | 2010 | 35 | 0.090 |
Why?
| Epigenesis, Genetic | 1 | 2014 | 374 | 0.090 |
Why?
| Chlamydia Infections | 1 | 2011 | 77 | 0.090 |
Why?
| Apolipoproteins E | 1 | 2010 | 56 | 0.090 |
Why?
| Nephrectomy | 1 | 2010 | 83 | 0.090 |
Why?
| Salicylates | 1 | 2009 | 14 | 0.090 |
Why?
| Scavenger Receptors, Class F | 1 | 2009 | 2 | 0.090 |
Why?
| Chelating Agents | 1 | 2009 | 27 | 0.090 |
Why?
| Inflammation | 1 | 2014 | 604 | 0.090 |
Why?
| Cell Line, Transformed | 1 | 2009 | 72 | 0.090 |
Why?
| Staphylococcal Infections | 1 | 2012 | 268 | 0.090 |
Why?
| Blood Proteins | 1 | 2010 | 82 | 0.090 |
Why?
| DNA Polymerase III | 1 | 2009 | 5 | 0.080 |
Why?
| Replication Protein C | 1 | 2009 | 5 | 0.080 |
Why?
| Replication Protein A | 1 | 2009 | 6 | 0.080 |
Why?
| Jejunum | 1 | 2009 | 54 | 0.080 |
Why?
| Green Fluorescent Proteins | 1 | 2009 | 90 | 0.080 |
Why?
| Fatty Liver | 1 | 2010 | 127 | 0.080 |
Why?
| Mice, Inbred Strains | 1 | 2009 | 161 | 0.080 |
Why?
| Zinc | 1 | 2009 | 53 | 0.080 |
Why?
| Ileum | 1 | 2009 | 89 | 0.080 |
Why?
| Autoantibodies | 1 | 2010 | 116 | 0.080 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 75 | 0.080 |
Why?
| Plasmids | 1 | 2009 | 161 | 0.080 |
Why?
| CHO Cells | 2 | 2006 | 120 | 0.080 |
Why?
| Cricetinae | 2 | 2006 | 192 | 0.080 |
Why?
| Radiation Injuries, Experimental | 1 | 2009 | 81 | 0.080 |
Why?
| Whole-Body Irradiation | 1 | 2009 | 131 | 0.080 |
Why?
| Lipids | 1 | 2009 | 147 | 0.080 |
Why?
| Oxidants | 2 | 2015 | 53 | 0.080 |
Why?
| Spleen | 1 | 2009 | 172 | 0.080 |
Why?
| RNA | 1 | 2009 | 170 | 0.080 |
Why?
| Dependovirus | 1 | 2009 | 101 | 0.080 |
Why?
| Sensitivity and Specificity | 2 | 2014 | 861 | 0.080 |
Why?
| Chronic Disease | 1 | 2010 | 567 | 0.080 |
Why?
| CpG Islands | 1 | 2008 | 108 | 0.080 |
Why?
| Ethanol | 1 | 2010 | 340 | 0.080 |
Why?
| Myocytes, Smooth Muscle | 1 | 2008 | 86 | 0.080 |
Why?
| Survival Analysis | 1 | 2009 | 653 | 0.080 |
Why?
| Cytoprotection | 1 | 2007 | 35 | 0.070 |
Why?
| Bone Marrow | 1 | 2009 | 362 | 0.070 |
Why?
| Cell Size | 1 | 2007 | 45 | 0.070 |
Why?
| Reactive Oxygen Species | 2 | 2015 | 408 | 0.070 |
Why?
| Myocardial Reperfusion Injury | 1 | 2007 | 48 | 0.070 |
Why?
| Cell Count | 1 | 2007 | 147 | 0.070 |
Why?
| Gene Silencing | 1 | 2007 | 119 | 0.070 |
Why?
| Scavenger Receptors, Class E | 1 | 2009 | 204 | 0.070 |
Why?
| Nucleosomes | 1 | 2007 | 13 | 0.070 |
Why?
| Acute Disease | 1 | 2008 | 366 | 0.070 |
Why?
| Camptothecin | 1 | 2006 | 16 | 0.070 |
Why?
| K562 Cells | 1 | 2006 | 42 | 0.070 |
Why?
| MAP Kinase Signaling System | 1 | 2006 | 119 | 0.070 |
Why?
| Uterine Cervical Neoplasms | 1 | 2009 | 277 | 0.070 |
Why?
| Breast | 1 | 2006 | 85 | 0.070 |
Why?
| Models, Molecular | 1 | 2007 | 338 | 0.060 |
Why?
| Arteriosclerosis | 1 | 2005 | 54 | 0.060 |
Why?
| Interphase | 1 | 2005 | 10 | 0.060 |
Why?
| Biotin | 1 | 2005 | 45 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2007 | 973 | 0.060 |
Why?
| Cell Hypoxia | 1 | 2004 | 82 | 0.060 |
Why?
| Rabbits | 1 | 2005 | 370 | 0.060 |
Why?
| Glycerol | 1 | 2002 | 15 | 0.050 |
Why?
| Caspase Inhibitors | 1 | 2002 | 16 | 0.050 |
Why?
| Gentamicins | 1 | 2002 | 31 | 0.050 |
Why?
| Vesiculovirus | 1 | 2022 | 5 | 0.050 |
Why?
| Acetaminophen | 1 | 2006 | 283 | 0.050 |
Why?
| Coronary Artery Disease | 1 | 2006 | 274 | 0.050 |
Why?
| Plants | 1 | 2022 | 27 | 0.050 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2002 | 48 | 0.050 |
Why?
| Agriculture | 1 | 2022 | 19 | 0.050 |
Why?
| Molecular Weight | 1 | 2002 | 84 | 0.050 |
Why?
| Macaca mulatta | 1 | 2022 | 93 | 0.050 |
Why?
| Ki-67 Antigen | 1 | 2022 | 57 | 0.050 |
Why?
| Sequence Alignment | 1 | 2002 | 121 | 0.050 |
Why?
| DNA, Complementary | 1 | 2002 | 135 | 0.050 |
Why?
| Nucleic Acid Conformation | 1 | 2002 | 83 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2002 | 185 | 0.050 |
Why?
| Fumonisins | 1 | 2001 | 5 | 0.050 |
Why?
| Exons | 1 | 2002 | 95 | 0.050 |
Why?
| Oxygen | 1 | 2004 | 326 | 0.050 |
Why?
| Mitochondria, Heart | 2 | 2015 | 35 | 0.050 |
Why?
| Sequence Analysis, DNA | 1 | 2002 | 237 | 0.050 |
Why?
| Class III Phosphatidylinositol 3-Kinases | 1 | 2021 | 1 | 0.050 |
Why?
| Hydrogen Peroxide | 1 | 2001 | 115 | 0.050 |
Why?
| Hep G2 Cells | 1 | 2021 | 36 | 0.050 |
Why?
| Drosophila | 1 | 2021 | 17 | 0.050 |
Why?
| Female | 5 | 2014 | 26472 | 0.050 |
Why?
| 14-3-3 Proteins | 1 | 2021 | 18 | 0.050 |
Why?
| Base Sequence | 1 | 2002 | 643 | 0.050 |
Why?
| Intestines | 1 | 2022 | 176 | 0.050 |
Why?
| Transcription, Genetic | 1 | 2002 | 369 | 0.050 |
Why?
| Molecular Sequence Data | 1 | 2002 | 792 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2020 | 5 | 0.050 |
Why?
| Radiation | 1 | 2020 | 15 | 0.050 |
Why?
| Protein Biosynthesis | 1 | 2002 | 253 | 0.040 |
Why?
| Caenorhabditis elegans | 1 | 2021 | 138 | 0.040 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2020 | 184 | 0.040 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2019 | 20 | 0.040 |
Why?
| Phosphorylation | 1 | 2021 | 535 | 0.040 |
Why?
| Transcriptome | 1 | 2021 | 315 | 0.040 |
Why?
| Microbial Sensitivity Tests | 1 | 2019 | 269 | 0.040 |
Why?
| Mitochondria | 1 | 2021 | 402 | 0.040 |
Why?
| Amino Acid Substitution | 1 | 2017 | 82 | 0.040 |
Why?
| Mice, Transgenic | 1 | 2017 | 555 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2020 | 976 | 0.030 |
Why?
| Pyrones | 1 | 2015 | 8 | 0.030 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2015 | 38 | 0.030 |
Why?
| Biphenyl Compounds | 1 | 2015 | 31 | 0.030 |
Why?
| Thiophenes | 1 | 2015 | 36 | 0.030 |
Why?
| Surface Plasmon Resonance | 1 | 2014 | 22 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2014 | 68 | 0.030 |
Why?
| 5-Methylcytosine | 1 | 2014 | 16 | 0.030 |
Why?
| L-Lactate Dehydrogenase | 1 | 2014 | 65 | 0.030 |
Why?
| Spectrum Analysis, Raman | 1 | 2014 | 58 | 0.030 |
Why?
| Metal Nanoparticles | 1 | 2014 | 84 | 0.030 |
Why?
| Protein Kinase Inhibitors | 1 | 2015 | 204 | 0.030 |
Why?
| Protein Binding | 1 | 2015 | 660 | 0.030 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.030 |
Why?
| Photochemical Processes | 1 | 2012 | 9 | 0.030 |
Why?
| Color | 1 | 2012 | 22 | 0.030 |
Why?
| Complementary Therapies | 1 | 2012 | 25 | 0.030 |
Why?
| Lipoproteins | 1 | 2012 | 39 | 0.030 |
Why?
| Light | 1 | 2012 | 71 | 0.030 |
Why?
| Molecular Imaging | 1 | 2012 | 53 | 0.030 |
Why?
| Lasers | 1 | 2012 | 123 | 0.030 |
Why?
| Mice, Nude | 1 | 2012 | 252 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 388 | 0.030 |
Why?
| Photoacoustic Techniques | 1 | 2012 | 72 | 0.020 |
Why?
| Hot Temperature | 1 | 2012 | 207 | 0.020 |
Why?
| Interferon-beta | 1 | 2011 | 29 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2011 | 29 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 50 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 51 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2011 | 172 | 0.020 |
Why?
| Hedgehog Proteins | 1 | 2010 | 33 | 0.020 |
Why?
| Liver Regeneration | 1 | 2010 | 49 | 0.020 |
Why?
| Models, Animal | 1 | 2011 | 233 | 0.020 |
Why?
| Neoplasms | 1 | 2020 | 1235 | 0.020 |
Why?
| Middle Aged | 1 | 2005 | 12069 | 0.020 |
Why?
| Enteral Nutrition | 1 | 2010 | 147 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2010 | 175 | 0.020 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2010 | 195 | 0.020 |
Why?
| RNA, Neoplasm | 1 | 2009 | 44 | 0.020 |
Why?
| Parvoviridae Infections | 1 | 2009 | 20 | 0.020 |
Why?
| Adult | 1 | 2005 | 13236 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2011 | 338 | 0.020 |
Why?
| Keratinocytes | 1 | 2009 | 90 | 0.020 |
Why?
| Cytokines | 1 | 2011 | 612 | 0.020 |
Why?
| Extracellular Matrix Proteins | 1 | 2008 | 69 | 0.020 |
Why?
| Apoptosis Inducing Factor | 1 | 2007 | 4 | 0.020 |
Why?
| Citrate (si)-Synthase | 1 | 2007 | 11 | 0.020 |
Why?
| Virus Replication | 1 | 2009 | 140 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 411 | 0.020 |
Why?
| Oxygen Consumption | 1 | 2007 | 183 | 0.020 |
Why?
| Gene Expression | 1 | 2009 | 609 | 0.020 |
Why?
| NAD | 1 | 2006 | 43 | 0.020 |
Why?
| Calcium | 1 | 2007 | 396 | 0.020 |
Why?
| Necrosis | 1 | 2006 | 176 | 0.020 |
Why?
| Cholesterol, LDL | 1 | 2005 | 34 | 0.020 |
Why?
| Liver Diseases | 1 | 2006 | 78 | 0.020 |
Why?
| Deoxyuracil Nucleotides | 1 | 2005 | 2 | 0.020 |
Why?
| Biotinylation | 1 | 2005 | 26 | 0.020 |
Why?
| Cell Membrane Permeability | 1 | 2005 | 28 | 0.020 |
Why?
| Cricetulus | 1 | 2005 | 97 | 0.020 |
Why?
| Adenosine Triphosphate | 1 | 2006 | 233 | 0.020 |
Why?
| Glutathione | 1 | 2006 | 295 | 0.020 |
Why?
| LLC-PK1 Cells | 1 | 2001 | 7 | 0.010 |
Why?
| Sphingomyelins | 1 | 2001 | 8 | 0.010 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 2001 | 10 | 0.010 |
Why?
| Ceramides | 1 | 2001 | 28 | 0.010 |
Why?
| Carboxylic Acids | 1 | 2001 | 17 | 0.010 |
Why?
| Swine | 1 | 2001 | 393 | 0.010 |
Why?
|
|
Basnakian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|